Presence of infection influences the epithelial lining fluid penetration of oral levofloxacin in adult patients

International Journal of Antimicrobial Agents

Volumn 45, Issue 5, 2015, Pages 512-518

  Kuti, Joseph L ^a   Nicolau, David P ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

ELF; Epithelial lining fluid; Fluoroquinolone; Pneumonia; Pulmonary penetration

Indexed keywords

ANTIINFECTIVE AGENT; LEVOFLOXACIN;

ADULT; AGED; BRONCHITIS, CHRONIC; CHEMISTRY; FEMALE; HUMAN; LUNG; MALE; MIDDLE AGED; PLASMA; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BRONCHITIS, CHRONIC; FEMALE; HUMANS; LEVOFLOXACIN; LUNG; MALE; MIDDLE AGED; MODELS, STATISTICAL; PLASMA; RETROSPECTIVE STUDIES;

EID: 84939958041     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.12.028     Document Type: Article

References (36)

1. D.E. Nix Intrapulmonary concentrations of antimicrobial agents Infect Dis Clin North Am 12 1998 631 646
2. S. Kiem, and J.J. Schentag Interpretation of antibiotic concentration ratios measured in epithelial lining fluid Antimicrob Agents Chemother 52 2008 24 36
3. K.A. Rodvold, J.M. George, and L. Yoo Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents Clin Pharmacokinet 50 2011 637 664
4. A.N. Deitchman, and H. Derendorf Measuring drug distribution in the critically ill patient Adv Drug Deliv Rev 77 2014 22 26
5. A. Torres, and A. Liapikou Levofloxacin for the treatment of respiratory tract infections Expert Opin Pharmacother 13 2012 1203 1212
6. G.L. Drusano, S.L. Preston, M.H. Gotfried, L.H. Danziger, and K.A. Rodvold Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and Monte Carlo simulation Antimicrob Agents Chemother 46 2002 586 589
7. B. Capitano, H.M. Mattoes, E. Shore, A. O'Brien, S. Braman, and C. Sutherland et al. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults Chest 125 2004 965 973
8. E. Boselli, D. Breilh, T. Rimmelé, S. Djabarouti, M.C. Saux, and D. Chassard et al. Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia Crit Care Med 33 2005 104 109
9. J.E. Conte Jr., J.A. Golden, M. McIver, E. Little, and E. Zurlinden Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease Int J Antimicrob Agents 30 2007 422 427
10. J. Zhang, X. Xie, X. Zhou, Y.Q. Chen, J.C. Yu, and G.Y. Cao et al. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections J Clin Pharmacol 50 2010 922 928
11. D.P. Nicolau, C. Sutherland, D. Winget, and R.P. Baughman Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis Pulm Pharmacol Ther 25 2012 94 98
12. J.L. Crandon, A. Kim, and D.P. Nicolau Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs J Antimicrob Chemother 64 2009 837 839
13. R.A. Keel, J.L. Crandon, and D.P. Nicolau Pharmacokinetics and pulmonary disposition of tedizolid and linezolid in a murine pneumonia model under variable conditions Antimicrob Agents Chemother 56 2012 3420 3422
14. C.O. Onyeji, K.Q. Bui, R.C. Owens Jr., D.P. Nicolau, R. Quintiliani, and C.H. Nightingale Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia Int J Antimicrob Agents 12 1999 107 114
15. R. Leary, R. Jelliffe, A. Schumitzky, and M. Van Guilder An adaptive grid non-parametric approach to pharmacokinetic and dynamic (PK/PD) models Proceedings of the 14th IEEE Symposium on Computer-Based Medical Systems (CBMS) 26-27 July 2001, Bethesda, MD 2001 IEEE Computer Society Los Alamitos, CA 389 394
16. K. Yamaoka, T. Nakagawa, and T. Uno Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations J Pharmacokinet Biopharm 6 1978 165 175
17. Y. Tanigawara, H. Nomura, N. Kagimoto, K. Okumura, and R. Hori Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases Biol Pharm Bull 18 1995 315 320
18. C.A. Peloquin, D.J. Hadad, L.P. Molino, M. Palaci, W.H. Boom, and R. Dietze et al. Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis Antimicrob Agents Chemother 52 2008 852 857
19. D.Z. D'Argenio, A. Schumitzky, and X. Wang ADAPT 5 user's guide: pharmacokinetic/pharmacodynamic systems analysis software 2009 Biomedical Simulations Resource Los Angeles, CA
20. ® (levofloxacin) prescribing information September 2008 PriCara, a Division of Ortho-McNeil-Janssen Pharmaceuticals Inc. Raritan, NJ
21. B. Allegranzi, A. Cazzadori, G. Di Perri, S. Bonora, M. Berti, and L. Franchino et al. Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid J Antimicrob Chemother 46 2000 319 322
22. M.H. Gotfried, L.H. Danziger, and K.A. Rodvold Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects Chest 119 2001 1114 1122
23. J.E. Conte Jr., J.A. Golden, J. Kipps, and E. Zurlinden Intrapulmonary pharmacokinetics of linezolid Antimicrob Agents Chemother 46 2002 1475 1480
24. K.A. Rodvold, L.H. Danziger, and M.H. Gotfried Steady-state and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults Antimicrob Agents Chemother 47 2003 2450 2457
25. E. Boselli, D. Breilh, T. Rimmelé, S. Djabarouti, J. Toutain, and D. Chassard et al. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia Crit Care Med 33 2005 1529 1533
26. J.E. Conte Jr., J.A. Golden, M.G. Kelley, and E. Zurlinden Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem Int J Antimicrob Agents 26 2005 449 456
27. S.T. Housman, J.S. Pope, J. Russomanno, E. Salerno, E. Shore, and J.L. Kuti et al. Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers Antimicrob Agents Chemother 56 2012 2627 2634
28. E. Boselli, D. Breilh, A. Caillault-Sergent, S. Djabarouti, C. Guillaume, and F. Xuereb et al. Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia J Antimicrob Chemother 67 2012 1207 1210
29. J.A. Rebuck, D.N. Fish, and E. Abraham Pharmacokinetics and oral levofloxacin in critically ill adults in a medical intensive care unit Pharmacotherapy 22 2002 1216 1225
30. D. Xuan, M. Zhong, H. Mattoes, K.Q. Bui, J. McNabb, and D.P. Nicolau et al. Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model Antimicrob Agents Chemother 45 2001 794 799
31. P.G. Ambrose, D.M. Grasela, T.H. Grasela, J. Passarell, H.B. Mayer, and P.F. Pierce Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections Antimicrob Agents Chemother 45 2001 2793 2797
32. A. Louie, C. Freqeau, W. Liu, R. Kulawy, and G.L. Drusano Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targets Antimicrob Agents Chemother 53 2009 3325 3330
33. K.A. Rodvold, D.P. Nicolau, T.P. Lodise, M. Khashab, G.J. Noel, and J.B. Kahn et al. Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole Antimicrob Agents Chemother 53 2009 3294 3301
34. T.W. Felton, K. McCalman, I. Malagon, B. Isalska, S. Whalley, and J. Goodwin et al. Pulmonary penetration of piperacillin and tazobactam in critically ill patients Clin Pharmacol Ther 96 2014 438 448
35. T.P. Lodise, F. Sorgel, D. Melnick, B. Mason, M. Kinzig, and G.L. Drusano Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia Antimicrob Agents Chemother 55 2011 1606 1610
36. B.R. Overholser, M.B. Kays, S. Lagvankar, M. Goldman, B.A. Mueller, and K.M. Sowinski Pharmacokinetics of intravenously administered levofloxacin in men and women Pharmacotherapy 25 2005 1310 1318